product summary
Loading...
company name :
R&D Systems
product type :
protein
product name :
Recombinant Human IL-1ra/IL-1F3 Protein, CF
catalog :
280-RA-010/CF
quantity :
10 ug (also 50 ug)
price :
355 USD
more info or order :
citations: 54
Reference |
---|
Messerschmidt L, Fischer S, Wiedemann P, Bringmann A, Hollborn M. Osmotic induction of cyclooxygenase-2 in RPE cells: Stimulation of inflammasome activation. Mol Vis. 2019;25:329-344 pubmed
|
Delaloye J, Filali Mouhim A, Cameron M, Haddad E, Harari A, Goulet J, et al. Interleukin-1- and type I interferon-dependent enhanced immunogenicity of an NYVAC-HIV-1 Env-Gag-Pol-Nef vaccine vector with dual deletions of type I and type II interferon-binding proteins. J Virol. 2015;89:3819-32 pubmed publisher
|
Marotta D, Costa R, Motta E, Fernandes E, Medeiros R, Quintão N, et al. Mechanisms underlying the nociceptive responses induced by platelet-activating factor (PAF) in the rat paw. Biochem Pharmacol. 2009;77:1223-35 pubmed
|
Wilson H, Varcoe R, Stokes L, Holland K, Francis S, Dower S, et al. P2X receptor characterization and IL-1/IL-1Ra release from human endothelial cells. Br J Pharmacol. 2007;151:115-27 pubmed
|
Fitzgerald D, Meade K, McEvoy A, Lillis L, Murphy E, MacHugh D, et al. Tumour necrosis factor-alpha (TNF-alpha) increases nuclear factor kappaB (NFkappaB) activity in and interleukin-8 (IL-8) release from bovine mammary epithelial cells. Vet Immunol Immunopathol. 2007;116:59-68 pubmed
|
Maedler K, Schumann D, Sauter N, Ellingsgaard H, Bosco D, Baertschiger R, et al. Low concentration of interleukin-1beta induces FLICE-inhibitory protein-mediated beta-cell proliferation in human pancreatic islets. Diabetes. 2006;55:2713-22 pubmed
|
Peng H, Erdmann N, Whitney N, Dou H, Gorantla S, Gendelman H, et al. HIV-1-infected and/or immune activated macrophages regulate astrocyte SDF-1 production through IL-1beta. Glia. 2006;54:619-29 pubmed
|
Hatfield K, Ryningen A, Corbascio M, Bruserud O. Microvascular endothelial cells increase proliferation and inhibit apoptosis of native human acute myelogenous leukemia blasts. Int J Cancer. 2006;119:2313-21 pubmed
|
Janes K, Gaudet S, Albeck J, Nielsen U, Lauffenburger D, Sorger P. The response of human epithelial cells to TNF involves an inducible autocrine cascade. Cell. 2006;124:1225-39 pubmed
|
Kao C, Chen Y, Thai P, Wachi S, Huang F, Kim C, et al. IL-17 markedly up-regulates beta-defensin-2 expression in human airway epithelium via JAK and NF-kappaB signaling pathways. J Immunol. 2004;173:3482-91 pubmed
|
Wolk K, Kunz S, Witte E, Friedrich M, Asadullah K, Sabat R. IL-22 increases the innate immunity of tissues. Immunity. 2004;21:241-54 pubmed
|
Morita K, Miyasako T, Kitayama S, Dohi T. Interleukin-1 inhibits voltage-dependent P/Q-type Ca2+ channel associated with the inhibition of the rise of intracellular free Ca2+ concentration and catecholamine release in adrenal chromaffin cells. Biochim Biophys Acta. 2004;1673:160-9 pubmed
|
Kawano Y, Fukuda J, Itoh H, Takai N, Nasu K, Miyakawa I. The effect of inflammatory cytokines on secretion of macrophage colony-stimulating factor and monocyte chemoattractant protein-1 in human granulosa cells. Am J Reprod Immunol. 2004;52:124-8 pubmed
|
Copeland S, Siddiqui J, Remick D. Direct comparison of traditional ELISAs and membrane protein arrays for detection and quantification of human cytokines. J Immunol Methods. 2004;284:99-106 pubmed
|
Liu R, Lioté F, Rose D, Merz D, Terkeltaub R. Proline-rich tyrosine kinase 2 and Src kinase signaling transduce monosodium urate crystal-induced nitric oxide production and matrix metalloproteinase 3 expression in chondrocytes. Arthritis Rheum. 2004;50:247-58 pubmed
|
Schaub F, Liles W, Ferri N, Sayson K, Seifert R, Bowen Pope D. Fas and Fas-associated death domain protein regulate monocyte chemoattractant protein-1 expression by human smooth muscle cells through caspase- and calpain-dependent release of interleukin-1alpha. Circ Res. 2003;93:515-22 pubmed
|
Park J, Kim Y, Jee Y, Myong N, Lee K. Interleukin-8 production in tuberculous pleurisy: role of mesothelial cells stimulated by cytokine network involving tumour necrosis factor-alpha and interleukin-1 beta. Scand J Immunol. 2003;57:463-9 pubmed
|
Lindemann S, Tolley N, Dixon D, McIntyre T, Prescott S, Zimmerman G, et al. Activated platelets mediate inflammatory signaling by regulated interleukin 1beta synthesis. J Cell Biol. 2001;154:485-90 pubmed
|
product information
brand :
R&D Systems
master code :
280-RA/CF
SKU :
280-RA-010/CF
product name :
Recombinant Human IL-1ra/IL-1F3 Protein, CF
unit size :
10 ug (also 50 ug)
seo description :
The Recombinant Human IL-1ra/IL-1F3 Protein, CF from R&D Systems is derived from E. coli. The Recombinant Human IL-1ra/IL-1F3 Protein, CF has been validated for the following applications: Bioactivity.
target :
IL-1ra/IL-1F3
category :
Proteins and Enzymes
buffer :
Lyophilized from a 0.2 ╡m filtered solution in PBS.
conjugate :
Unconjugated
dilution :
Bioactivity
purity :
>97%, by SDS-PAGE under reducing conditions and visualized by silver stain.
species :
Human
theoretical molecular weight :
17 kDa
gene symbol :
IL1RN
details of functionality :
Measured by its ability to inhibit IL-1 alpha -dependent proliferation in D10.G4.1 mouse helper T cells. Symons, J.A. etáal . (1987) in Lymphokines and Interferons, a Practical Approach. Clemens, M.J. etáal . (eds): IRL Press. 272. The ED50 for this effect is 5-40 ng/mL in the presence of 50 pg/mL of rhIL-1 alpha .
endotoxin note :
<0.10 EU per 1 ╡g of the protein by the LAL method.
top caption :
Recombinant Human IL-1ra/IL-1F3 Protein Bioactivity
accessionNumbers :
P18510
applications :
Bioactivity
source :
E. coli-derived Recombinant Human IL-1ra/IL-1F3 Protein, CF
USD :
355 USD
alt names :
DIRA, ICIL-1RA, IL1F3, IL-1F3, IL-1ra, IL1RA, IL-1ra3, IL1RN, IL-1RN, interleukin 1 receptor antagonist, IRAP, MVCD4
storage :
Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70 ░C as supplied. 1 month, 2 to 8 ░C under sterile conditions after reconstitution. 3 months, -20 to -70 ░C under sterile conditions after reconstitution.
more info or order :
company information

R&D Systems
614 McKinley Place N.E.
Minneapolis, MN 55413
Minneapolis, MN 55413
info@RnDSystems.com
https://www.rndsystems.com800 343-7475
headquarters: USA
R&D Systems develops and manufactures high-quality proteins and serves as a world leader in immunoassays. R&D Systems also produces quality antibodies, antibody arrays, stem cell and cell culture products, and cell selection and detection products, serving the life science and diagnostics industry.
related products
browse more products
questions and comments